Kun‐Lung Chuang

ASC-J9 Suppresses Castration-Resistant Prostate Cancer Growth through Degradation of Full-length and Splice Variant Androgen Receptors

Shinichi Yamashita, Kuo-Pao Lai, Kun‐Lung Chuang et al. · Neoplasia · 2012 · 140 citations · Full text

Androgen Receptor, Urology, Genitourinary Cancer +10

Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer

Mu‐Yi Hua, Hung‐Wei Yang, Cheng‐Keng Chuang et al. · Biomaterials · 2010 · 128 citations

Nanoparticles, Nanomedicine, Engineering +5

Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy

Mu‐Yi Hua, Hung‐Wei Yang, Hao-Li Liu et al. · Biomaterials · 2011 · 85 citations

Nanoparticles, Nanomedicine, Magnetism +13

Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development

Iawen Hsu, Kun‐Lung Chuang, Spencer Slavin et al. · Carcinogenesis · 2013 · 82 citations

Age-related reference levels of serum prostate-specific antigen among Taiwanese men without clinical evidence of prostate cancer.

Kuo-Jen Lin, See‐Tong Pang, Ying‐Hsu Chang et al. · PubMed · 2010 · 21 citations